The global hysteroscope market is expected to grow at a CAGR of 4.5% during the period 2016 – 2022. The global market is increasing, due to growing female geriatric population and increasing incidence of uterine cancer. In addition, the growing female infertility cases, increasing cases with abnormal uterine bleeding and growing demand of minimally invasive treatments is encouraging the growth of the global hysteroscope market.
The increasing aging population is propelling the growth of the global hysteroscope market, as the elderly population is more susceptible to gynaecological problems, such as abnormal uterine bleeding, fibroids, and polyps, as compared to adults, which is fuelling the demand hysteroscopes. Aging leads to changes in hormones leading to irregular menses, which contribute to the demand for hysteroscopy, thus driving the growth of the market.
Hysteroscopy is done to detect the cause of infertility, as it carefully evaluates the uterine cavity. It searches for any intrauterine lesions, polyps, myomas, adhesions, malformations, and carcinoma inside the uterus. It provides more accurate diagnosis, as well as treatment of such abnormalities under visual control, and is effective in improving pregnancy rates in sub-fertile women. These features make hysteroscopy more popular for diagnosis and treatment of infertility cases, thus leading to the growth of the hysteroscope market around the world.
The advantageous features of minimal invasive surgeries attract the patients around the world to opt for such procedures, instead of going for a traditional surgery. Open surgeries or traditional surgeries involve the formation of large incisions, which require long healing duration and also lead to long stay at the hospital. On the other hand, hysteroscopy doesn’t lead to any incision; rather the hysteroscope enters through the cervix directly into the uterine cavity for diagnosis and treating purposes. In addition, hysteroscopy leads to less blood loss, quick recovery time and less hospital, which is again fuelling the growth of the global hysteroscope market.
However, the availability of alternative diagnosis and treatment options, including drug therapies and other diagnostic procedures, such as blood test and ultrasound are inhibiting the growth of the hysteroscope market, as they are well known and widely adopted therapies for the treatment of gynaecological problems. In addition, the high cost of hysteroscopy procedure, in comparison to medication therapy and side effects associated with the usage of hysteroscopes is further restraining the growth of the market. The Asian market is expected to witness the fastest growth during the period 2016 – 2022.
The key companies operating in the global hysteroscope market include KARL STORZ GmbH & Co. KG, Olympus Corporation, Stryker, Richard Wolf GmbH, B. Braun Melsungen AG, Hologic Inc., MedGyn Products Inc., and Xion Medical GmbH.
News Courtesy: P&S Market Research